This course will provide a summary of the best-evidence treatments for Parkinson’s disease, drug-induced movement disorders, and a select group of other movement disorders. Symptomatic and disease modifying therapies will be discussed and evidence-based approaches to achieve the best treatment outcomes in Parkinson’s disease and other movement disorder conditions will be reviewed. The motor complications of Parkinson’s disease will be described including strategies for managing on-off dopamine medication fluctuations. Finally, a model for optimal care including a collaborative care team will be discussed.
Describe deficits in Parkinson’s disease and atypical parkinsonian syndromes
State the role of the speech-language pathologist as a member of the collaborative care team
Describe approaches used in speech-language pathology intervention in Parkinson’s disease and atypical parkinsonian syndromes
Broadly discuss how a collaborative team provides optimal care for movement disorder
Using Parkinson’s disease as an example, discuss best evidence treatments and the role of the collaborative care team